Skip to main content
ZEPP $5.42 +1.12%
ZEPP logo

ZEPP · Zepp Health Corp

Track ZEPP — free
$5.42 +0.06 (+1.12%) At close · Aug 14
Market Cap
$79.48M
Shares
14.66M
All earnings calls

Earnings call · FY2025 Q3

Zepp Health Corp Q3 FY2025 Earnings Call

Zepp Health Corp Q3 FY2025 Earnings Call

Concluded Nov 4, 2025 Audio replay
Nov 4, 2025 49:45 23 turns
Period
FY2025 Q3
Runtime
49:45
Sources
2 artifacts

Executive readout · one minute

Call research workspace

Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.

Premium Product Launches 41 Supply Constraints 18 Gross Margin Expansion 13 Channel Mix and Online Growth 12 Product Roadmap and Cadence 12 Marketing Spend Discipline 8

Management tone

Confident

Net tone +68 · low hedging

Grounding quotes
  • “revenue grew 78.5% year-over-year, underscoring the ongoing effectiveness of our strategic brand and product evolution”
  • “We anticipate Q4 revenue to be between USD 82 million and USD 86 million, delivering 38% to 45% year-over-year growth”
  • “we've provided our guidance, and we aim to be cautious with our estimates”
  • “we also have issues when launching the first batch of the new products; we try to prioritize online over offline”

Forward guidance

1 guided metrics

Management's latest ranges and targets are included below.

Research coverage

2 live sources

Switch sources without leaving this page or losing your listening position.

Research materials

Open the source you need; every reader stays inside this workspace.

Company webcastOpen the original investor-relations page

Guidance from the call

Stated verbally and extracted from the transcript.

Metric Guided
Revenue
fourth quarter of 2025
$82M – $86M
Full-screen source Call document